Cargando…
Plasma from donors recovered from the new Coronavirus 2019 as therapy for critical patients with COVID-19 (COVID-19 plasma study): a multicentre study protocol
Since the end of 2019, a new coronavirus strain has been reported in the Chinese province of Wuhan, indicated as 2019-nCoV or SARS-CoV-2. In February 2020, the first case of transmission on Italian soil was reported. On March 09, 2020, at the time of protocol design, the Italian Ministry of Health r...
Autores principales: | Perotti, Cesare, Del Fante, Claudia, Baldanti, Fausto, Franchini, Massimo, Percivalle, Elena, Vecchio Nepita, Edoardo, Seminari, Elena, De Silvestri, Annalisa, Bruno, Raffele, Klersy, Catherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8849045/ https://www.ncbi.nlm.nih.gov/pubmed/32468508 http://dx.doi.org/10.1007/s11739-020-02384-2 |
Ejemplares similares
-
Mortality reduction in 46 patients with severe COVID-19 treated with hyperimmune plasma. A proof-of-concept, single-arm, multicenter trial
por: Perotti, Cesare, et al.
Publicado: (2020) -
Impact of pathogen reduction technology on neutralizing antibody titer in COVID-19 convalescent plasma
por: Franchini, Massimo, et al.
Publicado: (2022) -
Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy
por: Lenti, Marco Vincenzo, et al.
Publicado: (2020) -
SARS-CoV-2 variants inactivation of plasma units using a riboflavin and ultraviolet light-based photochemical treatment
por: Ferrari, Alessandro, et al.
Publicado: (2022) -
A randomized clinical trial evaluating the immunomodulatory effect of convalescent plasma on COVID-19-related cytokine storm
por: Pouladzadeh, Mandana, et al.
Publicado: (2021)